Ibrutinib and ublituximab – a promising combination regimen for treating CLL?
iwCLL – International Workshop on Chronic Lymphocytic Leukemia
Federico Caligaris-Cappio et al.
The role of transplant in the era of new treatments for lymphoma and CLL
Better survival outcomes with the use of new CLL drugs
A decade of advances in multiple myeloma and unanswered questions